Antimicrobial resistance in nephrology
Tina Z Wang1, Rosy Priya L Kodiyanplakkal2, David P Calfee3,4
1NewYork Presbyterian-Weill Cornell Medical Center, New York, NY, USA.
Antimicrobial resistance (AMR) is rising in bacterial pathogens, especially in patients with chronic kidney disease. New antibiotics are needed, alongside improved infection prevention, to combat this growing threat.
Area of Science:
- Infectious Diseases
- Nephrology
- Microbiology
Background:
- Antimicrobial resistance (AMR) is a growing global health concern, driven by factors including antibiotic use and international travel.
- Patients with chronic kidney disease (CKD), particularly those on dialysis or post-transplant, exhibit high rates of colonization and infection with antibiotic-resistant bacteria (ARB).
- Common ARB in CKD patients include methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), and multidrug-resistant Gram-negative organisms.
Purpose of the Study:
- To highlight the increasing prevalence of AMR in bacterial pathogens.
- To emphasize the vulnerability of patients with chronic kidney disease to ARB infections.
- To underscore the urgent need for novel therapeutic strategies and enhanced infection control measures.
Main Methods:
- This abstract synthesizes current knowledge on antimicrobial resistance trends and their impact on patients with renal disease.
- It reviews the types of antibiotic-resistant bacteria commonly found in this patient population.
- It discusses the challenges posed by emerging resistance to new antibiotic agents.
Main Results:
- Antimicrobial resistance is increasing among common bacterial pathogens.
- Patients with chronic kidney disease are disproportionately affected by antibiotic-resistant bacteria.
- Emerging resistance to new antibiotics necessitates continuous development of novel treatments.
Conclusions:
- Effective management of ARB in renal disease patients requires vigilance for local resistance patterns and adherence to infection prevention practices.
- There is a critical need for new antimicrobial agents and improved infection control strategies.
- Clinicians must stay informed about evolving resistance and implement robust prevention measures to mitigate morbidity and mortality.
More Related Videos
04:26Author Spotlight: Advancing Mycobacterial Biofilm Protocols for Enhanced Bacterial Metabolism Research
Published on: July 12, 2024
06:54Author Spotlight: Understanding and Detecting Environmental Antimicrobial Resistance by Combining Culture-Based Techniques and Genomics
Published on: July 19, 2024
Related Concept Videos
Antimicrobial Effectiveness
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Resistivity
Resistance
Resistance and Conductance
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...
Equivalent Resistance
